Morgan Stanley says US stock rally has limited upside

Morgan Stanley says US stock rally has limited upside
“The key fundamental call we are focused on now is slowing growth, and our view that earnings estimates are too high,” says Morgan Stanley’s Michael Wilson.
MAY 31, 2022

The relief rally in U.S. equities has limited scope to go much further as risks to growth remain prevalent, according to Morgan Stanley’s Michael Wilson.

“Last week’s strength will prove to be another bear market rally in the end,” the strategist wrote in a note. “The key fundamental call we are focused on now is slowing growth, and our view that earnings estimates are too high.”

Morgan Stanley sees the S&P 500 reaching a maximum of 4,250 to 4,300 points in the current rally, a 3.4% gain from Friday’s close. The Nasdaq and small cap stocks are likely to rebound more on a percentage basis, as they usually tend to do in such circumstances, Wilson said.

U.S. stocks have had a volatile month amid fears that the economy might enter a recession as the Federal Reserve tightens its policy to tame soaring prices. Still, the S&P 500 recovered last week, and is set for positive returns in May amid lower valuations and expectations inflation may be peaking.

Wilson continues to be among Wall Street’s most prominent bears and correctly predicted the latest market selloff. The strategist forecasts the S&P 500 will trade close to 3,400 by the end of the second-quarter earnings season in mid-August, implying 18% downside from its latest close.

“The primary rationale ascribed to this particular rally beyond just an oversold bounce is that the Fed may be contemplating a pause in September,” Wilson wrote. Still, “inflation remains too high for the Fed’s liking and so whatever pivot investors might be hoping for will be too immaterial to change the downtrend in Morgan equity prices.”

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor